Chronic hepatitis B virus (HBV) infection is a major cause of chronic liver disease and cancer worldwide. The mechanisms of viral genome sensing and the evasion of innate immune responses by HBV infection are still poorly understood. Recently, the cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) was identified as a DNA sensor. In this study, we investigated the functional role of cGAS in sensing HBV infection and elucidate the mechanisms of viral evasion. We performed functional studies including loss-of-function and gain-of-function experiments combined with cGAS effector gene expression profiling in an infectious cell culture model, primary human hepatocytes, and HBVinfected human liver chimeric mice. Here, we show that cGAS is expressed in the human liver, primary human hepatocytes, and human liver chimeric mice. While naked relaxed-circular HBV DNA is sensed in a cGAS-dependent manner in hepatoma cell lines and primary human hepatocytes, host cell recognition of viral nucleic acids is abolished during HBV infection, suggesting escape from sensing, likely during packaging of the genome into the viral capsid. While the hepatocyte cGAS pathway is functionally active, as shown by reduction of viral covalently closed circular DNA levels in gain-of-function studies, HBV infection suppressed cGAS expression and function in cell culture models and humanized mice. Conclusion: HBV exploits multiple strategies to evade sensing and antiviral activity of cGAS and its effector pathways. (HEPATOLOGY 2018; 68:1695-1709.
W ith more than 250 million chronically infected patients, hepatitis B virus (HBV) infection is a leading cause of liver disease and hepatocellular carcinoma. (1, 2) Current antiviral therapies effectively control viral load but largely fail to cure. (3) HBV is a partially double-stranded DNA (dsDNA) virus infecting human hepatocytes after initial attachment to heparan sulfate proteoglycans and its receptor Na 1 /taurocholate cotransporting polypeptide (NTCP; reviewed in Verrier et al. (4) ). Following uncoating, the viral nucleocapsid is released into the cytoplasm. The viral genome is imported into the nucleus through mechanisms which are still poorly understood. The viral genome is converted in the nucleus into a covalently closed circular DNA (ccc DNA). (5) This minichromosome serves as a template
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for both pregenomic RNA (pgRNA) and viral mRNA transcription. While recent studies have suggested sensing of the pgRNA or other HBV RNAs by either MDA5 (6) or RIG-I, (7) the recognition of the viral nucleic acids by the regular pattern recognition receptors remains elusive. In general, HBV does not or does only marginally activate innate immune responses in cell culture models and in vivo, (8) (9) (10) (11) (12) (13) (14) leading to the concept that HBV behaves like a "stealth" virus avoiding viral DNA and RNA sensing. (15) Other studies have suggested an active inhibition of the innate immune responses by HBV proteins. (16) Consequently, the interaction of HBV and the innate immune system of hepatocytes, and in particular the sensing of HBV DNA, is only poorly understood.
Foreign DNA recognition by cytosolic DNA sensors triggers an early antiviral innate immune response, including type I and type III interferon (IFN) production. (17) Recently, the cyclic guanosine monophosphateadenosine monophosphate (cGAMP) synthase (cGAS) was identified as a DNA sensor exhibiting antiviral activity against a broad range of DNA and RNA viruses. (18) (19) (20) cGAS is encoded by the Mab-21 domaincontaining protein 1 (MB21D1) gene and directly binds to dsDNAs, inducing the production of cGAMP, which is recognized by the stimulator of IFN genes (STING, encoded by transmembrane protein 173
[TMEM173]), triggering the expression of IFNstimulated genes (ISGs) through TANK binding kinase 1 (TBK1) activation. (21) (22) (23) While two studies have investigated cGAS-HBV interactions in viral replication and assembly, (24, 25) the functional role of cGAS in sensing of the viral genome during natural infection of human hepatocytes remains unknown.
The understanding of HBV-host interactions, including the innate immune response after infection, has been hampered for a long time by the absence of a robust cell culture model system for the study of viral infection. (26) The development of HBV-susceptible NTCP-overexpressing hepatoma cells, such as HepG2-NTCP cells, allows the study of the full life cycle in a robust and easy-to-use cell culture model. (26) HepG2 cells are capable of mounting an efficient innate immune response after infection by hepatitis C virus. (27) Moreover, another study took advantage of HBVinfected HepG2-NTCP for studying the interaction between RIG-I and HBV RNA, (7) suggesting that this cell line is suitable for the study of the innate immune response after HBV infection. Here, we aimed to understand the functional role of cGAS for the HBV life cycle in human hepatocytes and unravel the mechanisms of viral evasion using loss-of-function and gainof-function experiments combined with cGAS effector gene expression profiling in human liver chimeric mice.
Patients and Methods

HUMAN SUBJECTS
Human material including liver tissue from patients undergoing surgical resection or HBV-positive serum was obtained with informed consent from all patients. Protocols were approved by the Ethics Committee of the University of Strasbourg Hospitals, France (CPP 10-17 and DC-2016-2616).
ANIMAL EXPERIMENTATION
All mice were kept in a specific pathogen-free animal housing facility at Inserm UMRS_1110. The respective protocols were approved by the Ethics Committee of the University of Strasbourg Hospitals and authorized by the French Ministry of Research (nos. 02014120416254981AL/02/19/08/12, AL/01/18/08/ 1202014120416254981, 0201412051105 4408). Mice were kept in individual ventilated cages, with bedding composed of irradiated sawdust and chips from spruce and pine and enriched with cotton cocoon and aspen bricks. The animal diet consisted of 25 kGy irradiated RM3(E) (SDS) and mice were not fasted. Primary human hepatocytes (PHHs) were transplanted into 3-week-old urokinase-type plasminogen activator/severe combined immunodeficient beige (uPA/SCID-bg) mice (male and female) by intrasplenic injection as described. (28) Engraftment and viability of PHHs were assessed by quantification of human serum albumin by enzyme-linked immunosorbent assay (E80-129; Bethyl Laboratories). (28) uPA/SCID-bg mice were then infected with serum-derived HBV and sacrificed 16 weeks after virus inoculation. Serum HBV load was determined by quantitative PCR (Realtime HBV viral load kit; Abbott) before sacrifice. Interventions were all performed during light cycle.
CELL LINES AND HUMAN HEPATOCYTES
HEK 293T (29) and HepG2-NTCP (30) cells as well as isolation of PHHs have been described. (29) 
REAGENTS AND PLASMIDS
Dimethyl sulfoxide (DMSO), PEG 8000 (polyethylene glycol), polyinosinic:polycytidylic acid (poly [I:C]), and calf thymus DNA (control dsDNA) were obtained from Sigma-Aldrich; pReceiver-Lv151 plasmid was from GeneCopoeia; and lentiCas9-Blast and lentiGuide-Puro plasmids were gifts from Feng Zhang (Addgene 52962 and 52963).
SMALL INTERFERING RNAs FOR FUNCTIONAL STUDIES
Pools of ON-TARGET plus (Dharmacon) small interfering RNA (siRNA) targeting MB21D1 (cGAS), TMEM173 (STING), TBK1, and IFN-cinducible protein 16 (IFI16) expression were reversetransfected into HepG2-NTCP using Lipofectamine RNAi-MAX (Invitrogen) as described. (29) RNA was purified from cells harvested 2 days after transfection, and gene expression was analyzed using quantitative RT-PCR.
HepG2-NTCP-cGAS OVEREXPRESSING AND MB21D1 KNOCKOUT CELLS
Lentivirus particles were generated in HEK 293T cells by cotransfection of plasmids expressing the human immunodeficiency virus (HIV) gap-pol, the vesicular stomatitis virus glycoprotein, and either the human MB21D1 full open reading frame (ORF) encoding plasmid, the MB21D1-targeting singleguide RNA (sgRNA) encoding plasmids, or the clustered regularly interspaced short palindromic repeats (CRISPR)-associated 9 (Cas9) expressing plasmid, in a ratio of 10:3:10. HepG2-NTCP cells were then plated and transduced with lentivirus encoding either the human MB21D1 ORF or the ORF of the gene for enhanced green fluorescent protein in pReceiverLv151 vector (GeneCopoeia) as a control. After 3 days, transduced cells were selected with 200 lg/mL of neomycin (G418). The cGAS-overexpressing and control HepG2-NTCP cells were then further cultured in the presence of G418 at 200 lg/mL. For the generation of MB21D1 knockout (KO) cell lines, one MB21D1-targeting sgRNA was designed using CRISPR Design Tool (Broad Institute, http://www. genome-engineering.org/). The sgRNA sequence targeting exon 1 of MB21D1 (sgcGAS 5 0 -CACCGC GGCCCCCATTCTCGTACGG-3 0 ) was inserted into lentiGuide-Puro plasmid. (31) We first generated Cas9-expressing HepG2-NTCP cells after transduction of cells with the lentiCas9-Blast plasmid. (31) Cells were then selected with 6 lg/mL blasticidin for 10 days. HepG2-NTCP-Cas9 cells were seeded in sixwell plates at 50% confluence 24 hours prior to transduction with the sgcGAS-encoding plasmid. Subpopulations of cells were selected from the whole population and cultured independently. cGAS expression was controlled by western blot. Finally, two cGAS-KO cell lines (cGAS_KO#1 and cGAS_ KO#2) were selected.
ANALYSIS OF GENE EXPRESSION USING QUANTITATIVE RT-PCR
Total RNA was extracted using ReliaPrep RNA Miniprep Systems (Promega) and reverse-transcribed into complementary DNA (cDNA) using the Maxima First Strand cDNA Synthesis Kit (Thermo Scientific) according to the manufacturer's instructions. Gene expression was then quantified by quantitative PCR using a CFX96 thermocycler (Bio-Rad). Primers and TaqMan probes for MB21D1 (cGAS), TMEM173 (STING), TBK1, IFI16, IFN beta 1 (IFNB1), IFN lambda 1 (IFNL1), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA detection were obtained from ThermoFisher (TaqMan Gene Expression Assay; Applied Biosystems). All values were normalized to GAPDH expression.
PROTEIN EXPRESSION
The expression of cGAS, STING, and b-actin proteins was assessed by western blot as described (30) using two polyclonal rabbit anti-cGAS antibodies (HPA031700, Sigma, and NBP1-86761, Novus Biologicals; see Supporting Information), a polyclonal rabbit anti-STING antibody (19851-1-AP; Proteintech), and a monoclonal anti-b-actin antibody (mAbcam8226; Abcam). Protein expression was quantified using ImageJ software.
INFECTION OF HepG2-NTCP CELLS AND PHHs
The purification of infectious recombinant HBV particles from HepAD38 cells and infection of Hep G2-NTCP cells have been described. (30) Briefly, HepG2-NTCP and derived cells were plated 1 day prior to incubation with HBV in the presence of 4% PEG at a multiplicity of infection (MOI) of 500 GEq/cell except where otherwise stated. Sixteen hours after HBV inoculation, cells were washed with phosphate-buffered saline and then cultured in 3.5% DMSO primary hepatocyte maintenance medium for 10 days. HBV infection was assessed by quantification of HBV pgRNA using quantitative RT-PCR or HBV total DNA using quantitative PCR as described (30) or by immunofluorescence using anti-hepatitis B surface antigen (HBsAg) antibody (1044/329; Bio-Techne) and AF647-labeled goat antibody targeting mouse immunoglobulin Gs (115-605-003; Jackson Research) as described. (30) Southern blot detection of HBV cccDNA was performed using digoxigenin (DIG)-labeled (Roche) specific probes as described. (32) Total DNA from HBV-infected cells was extracted using the Hirt method as described. (33) Specific DIG-labeled probes for the detection of HBV and mitochondrial DNAs were synthetized using the PCR DIG Probe Synthesis Kit (Roche) and the primers indicated in Supporting Table S1 . PHHs were plated 1 day prior to incubation with a HBV preS1 or a control peptide for 1 hour at 378C as described. (30) PHHs were then infected with recombinant HBV particles for 10 days. HBV infection was assessed by quantification of HBV pgRNA using quantitative RT-PCR and immunofluorescence as described above.
SENDAI VIRUS INFECTION
HepG2-NTCP cells and PHHs were infected with Sendai virus (SeV) DI-H4 at an MOI of 10 as described. (13) 
EXTRACTION OF HBV RELAXED CIRCULAR DNA FROM HBV INFECTIOUS PARTICLES
HBV relaxed circular DNA (rcDNA) was extracted from HBV preparations using the QiaAMP DNA MiniKit protocol (Qiagen). PEG-precipitated cell supernatants from naive HepG2-NTCP cells were used as nonvirion controls. The presence of HBV DNA was confirmed by PCR and quantified by quantitative PCR as described (30) (see Supporting Information). One microgram of rcDNA or dsDNA (calf thymus DNA) was transfected in cells using Lipofectamine 2000 (Invitrogen) and the CalPhos Mammalian Transfection Kit (Clontech) according to the manufacturers' instructions. Cells transfected with HepG2-NTCP control supernatants were used as a control. Three days after transfection, total RNA was extracted and purified as described above.
TRANSCRIPTOMIC ANALYSIS BY DIGITAL MULTIPLEXED GENE PROFILING USING nCOUNTER NanoString
Transcriptomic analyses using nCounter NanoString were performed according to the manufacturer's instructions. Specific probes for a set of 36 innate antiviral response-related (IAR) genes (according to Schoggins et al. (20) and additional genes listed in Supporting Table S2 ) were obtained from the manufacturer. HepG2-NTCP cells, HepG2-NTCP-derived cell lines, and PHHs either were infected with HBV or SeV or were transfected with poly(I:C) (100 ng) for 2 days. Alternatively, HepG2-NTCP-Cas9 and HepG2-NTCP-KO_cGAS#2 cells were transfected with rcDNA (1 lg) or dsDNA (calf thymus DNA, 1 lg) for 3 days. Total RNA was then extracted and subjected to the nCounter Digital Analyzer system (NanoString). Alternatively, total liver RNA was extracted from HBV-infected mice, and gene expression was assessed by either quantitative RT-PCR (MB21D1 expression) or the nCounter Digital Analyzer system. The 36 genes were considered to be an artificial gene set, the IAR gene set. Its perturbation by infection, transfection, or gain-of-function/loss-offunction studies was assessed through gene set enrichment analysis (GSEA). (34) GSEA determines whether an a priori defined set of genes shows statistically significant differences between two biological states. A false discovery rate (FDR) < 0.05 was considered statistically significant. Heatmaps illustrating the induction (red) or repression (blue) of the genes of the IAR compared to control were illustrated using Morpheus software (Broad Institute of MIT and Harvard, Cambridge, MA). Heatmaps illustrating the induction (red) or repression (blue) of individual genes in chimeric mouse livers were designed using GenePattern (Broad Institute of MIT and Harvard).
FLUORESCENCE IN SITU HYBRIDIZATION ANALYSES
Fluorescence in situ hybridization (FISH) analyses were performed as described. (28, 35) Briefly, liver samples were collected from mice and then immediately embedded into optimal cutting temperature compound (OCT). OCT-embedded liver sections were cryosectioned (10 lm) using a cryostat (Leica). Upon fixation with 4% formaldehyde at 48C, washing, and dehydration in ethanol, tissue sections were boiled at 908C-958C for 1 minute in a pretreatment solution (Affymetrix-Panomics), followed by a 10-minute digestion in protease QF (Affymetrix-Panomics) at 408C. Sections were then hybridized using specific probe sets targeting HBV (target region nucleotides 483-1473 of HBV [genotype D, GenBank V01460]) and human MD2 1D1 (VA1-3013492-VC; Affymetrix-Panomics). Preamplification, amplification, and detection of bound probes were performed according to the manufacturer's instructions. Finally, pictures were acquired by confocal laser scanning microscopy (LSM710; Carl Zeiss Microscopy) and Zen2 software.
STATISTICAL ANALYSIS
Except where otherwise stated, cell culture experiments were performed at least 3 times in an independent manner. Statistical comparisons of the samples were performed using a two-tailed Mann-Whitney U test. For in vivo experiments, a two-tailed unpaired Student t test was performed for comparing gene expression from noninfected and HBV-infected mice. *P < 0.05, **P < 0.01, and ***P < 0.001 were considered significant. Significant P values are indicated by asterisks in the figures. Each digital multiplexed gene profiling experiment was performed using three biological replicates per condition, and the induction or repression of the gene set was analyzed using GSEA. FDR < 0.05 was considered statistically significant.
Results
EXPRESSION OF cGAS IN PHHs AND AN INFECTIOUS HBV CELL CULTURE MODEL
Prior to its functional characterization, we studied cGAS/MB21D1 expression in primary hepatocytes and HBV permissive cell lines. cGAS protein expression was easily detectable in PHHs from three independent donors (Fig. 1A) . Because HBV infection of primary cells is highly variable and does not allow robust perturbation studies, we used an HBV infectious cell culture model based on differentiated hepatocyte-derived HepG2 cells overexpressing NTCP (30) -a key HBV entry factor. cGAS protein is expressed in HepG2-NTCP cells (Fig. 1A) . We validated the specificity of cGAS detection using an siRNA specifically targeting the MD21B1 expression (sicGAS) and western blots applying two antibodies ( Fig. 1A; Supporting Fig. S1 ). Moreover, we generated CRISPR-mediated MB21D1 KO cells using a specific sgRNA (Fig. 1B) . Two cell lines, KO_cGAS#1 and KO_cGAS#2, were selected for further studies (Fig.  1B) . Interestingly, the adaptor STING was also detected in HepG2-NTCP cells, suggesting a fully functional cGAS-STING pathway (Fig. 1C) . To test the suitability of these cells as a model to analyze cGAS-mediated innate immune response after virus infection, we stimulated cells with different analogues of viral nucleic acids. Stimulation by poly(I:C) or dsDNA transfection elicited dose-dependent IFNB1 expression in HepG2-NTCP cells (Fig. 1D) . These results suggest that the cGAS sensing machinery is present and functional, even if it is less efficient than the RNA sensing complex. Moreover, cGAS protein expression was induced by both poly(I:C) and dsDNA stimulation, confirming an efficient IFN response through the upregulation of ISGs such as MB21D1 (36) after RNA or DNA stimulation (Fig. 1E) . Collectively, these data show that the HepG2-NTCP model is suitable to study innate immune responses. 
HBV EVADES cGAS SENSING
Next, we investigated whether HBV was sensed in HBV permissive cells. To address this question, we infected HepG2-NTCP cells with recombinant HBV (MOI, 500 GEq/cell) and studied the expression of IFNB1 at early time points after HBV infection. Because it has been described that HBV infection may induce the expression of type III IFN, (7) IFNL1 expression was also quantified. The lack of increase in IFNB1 and IFNL1 expression despite efficient infection (Supporting Fig. S2) indicates poor or absent detection of HBV by cellular sensors (Fig. 2A,B) . In contrast, SeV, known to induce a strong IFN response in hepatocytes, (13) strongly induced IFNB1 and IFNL1 expression (Fig. 2 A, B) . Because cGAS has been shown to induce the expression of a large set of innate effector genes (such as OAS2 and IFI44, see Schoggins et al. (20) ), the analysis of expression of a single effector gene such as IFNB1 may not be sufficient to evaluate cGAS sensing. Therefore, we designed a 36 IAR gene set, comprising 29 ISGs whose expression is modulated by cGAS activity described by Schoggins et al. (20) as well as seven established innate immune response effector genes (Supporting Table  S2 ). We then infected HepG2-NTCP cells with HBV or SeV and measured the innate antiviral immune response at day 2 postinfection by analysis of IAR gene
FIG. 2. Impaired cGAS-mediated sensing of HBV infection in HepG2-NTCP cells. (A,B) HBV infection does not induce IFNB1
or IFNL1 expression. HepG2-NTCP cells were infected with HBV (MOI, 500) or SeV (MOI, 10), and total RNA was extracted every day for 3 days. RNA extracted from naive cells before infection was used as a control (D0). IFNB1 (A) and IFNL1 (B) expression was then assessed by quantitative RT-PCR. Results are expressed as means 6 SD IFNB1/IFNL1 relative expression (log10) compared to controls (D0, all set at 1) from three independent experiments performed at least in duplicate (SeV) or four independent experiments performed in duplicate (HBV). No robust IFNL1 expression was detected in HBV-infected samples (representative dots are presented under the "detection limit" dotted line). (C,E) cGAS-related ISGs are not affected by HBV infection. HepG2-NTCP cells were infected with HBV or SeV. Alternatively, HepG2-NTCP cells were transfected with poly(I:C) (100 ng). Two days after infection or transfection, total RNA was extracted. Gene expression of IAR signature was then analyzed using multiplexed gene profiling. Results were analyzed by GSEA compared to nontransfected or noninfected controls (C) or by IFNB1 and IFI44 gene expression (log10) compared to nontransfected or noninfected controls (set at 1) (E). One experiment performed in triplicate is shown. (D,F) The cGAS expression level does not affect the cellular response to HBV infection. HepG2-NTCP-Cas9 (Cas9), HepG2-NTCPKO_cGAS#2 (Ko_cGAS#2), HepG2-NTCP-Ctrl_ORF (Ctrl_ORF), and HepG2-NTCP-cGAS_OE (cGAS_OE) were infected with HBV. Two days after infection, total RNA was extracted. Gene expression of IAR signature gene set was then analyzed using multiplexed gene profiling. Results were analyzed by GSEA compared to nontransfected or noninfected controls (D) or by IFNB1 and IFI44 gene expression (log10) compared to nontransfected or noninfected controls (set at 1) (F). One experiment performed in triplicate is shown. expression using digital multiplexed gene profiling (nCounter NanoString) and GSEA-based analysis. Whereas poly(I:C) transfection and SeV infection induced a marked modulation of cGAS effector/IAR gene expression (FDR, 0.004 and <0.001, respectively), no significant modulation of IAR gene expression was observed in HBV-infected cells (Fig. 2C) , as further illustrated by the expression of IFNB1 and IFI44 (Fig. 2E) . To measure the impact of cGAS expression on the cellular response to HBV infection, we then infected cGAS-depleted (KO_cGAS#2) and cGAS-overexpressing (cGAS_OE) HepG2-NTCP cells with HBV and analyzed the expression of the cGAS-related genes after infection. No significant modulation of the IAR signature was observed in HBV-infected samples (Fig. 2D) , as further illustrated by absent modulation of IFNB1 and IFI44 expression (Fig. 2F) .
To exclude the possibility that low HBV infection could be the reason for the absence of IFN induction, we performed additional experiments using increasing MOIs. No induction of IFNB1 (Fig. 3A) was observed even at an MOI of 10,000, despite very high infection efficiency as shown by quantitation of pgRNA and immunofluorescence of HBsAg (Fig. 3B,C) . To investigate whether IFN induction occurs potentially at a very early step of viral infection and was missed in the experimental design shown above, we performed a time course study of the IFN response to HBV within the first 24 hours postinfection. HBV infection did not induce a measurable IFN response during early steps of HBV infection (Fig. 3D) . In contrast, SeV, an established inducer of IFN, showed robust induction of IFN responses in HepG2-NTCP cells (Fig. 3D) . Taken together, these data suggest an absence of sensing of HBV infection by the cGAS-STING pathway in HepG2-NTCP cells.
Because the HBV genome is packaged into the nucleocapsid, (37) we investigated whether packaging shields virion DNA from cGAS recognition. We purified HBV genomic rcDNA from HBV infectious particles (Supporting Fig. S3 ) and transfected the naked viral genome into HepG2-NTCP cells (1 lg, corresponding to approximately 10 6 -10 7 HBV DNA copies/lL). A significant (FDR, 0.02) induction of the IAR signature (illustrated by IFNB1 and IFI44 expression, Fig. 4B ) was observed after both rcDNA and dsDNA transfection, suggesting sensing of the naked HBV genome (Fig. 4A) . Interestingly, the number of cellular HBV DNA copies was higher in HBVinfected cells compared to rcDNA-transfected cells (Fig. 4C) , confirming that the levels of HBV DNA in HBV-infected cells are sufficient to trigger IFN signaling and that the absence of HBV sensing in infected cells was not due to low MOIs. Moreover, induction of IAR gene expression was absent in HepG2-NTCPKO_cGAS#2 cells, suggesting a cGAS-specific activation of innate immunity by both dsDNA and rcDNA transfection in our model.
To validate these observations in a more physiological model, we infected PHHs with HBV and controlled cGAS gene expression after 2 days of infection. Interestingly, while SeV strongly induced IAR gene expression (Fig. 5B) , a highly efficient HBV infection (Fig.  5A) did not induce the expression of IAR genes (Fig.  5B) . In contrast, the transfection of rcDNA and dsRNA into PHHs from 4 different donors robustly triggered the expression of IFNB1 and IFNL1 (Fig.  5C ), suggesting a robust sensing of viral DNA in human hepatocytes. Collectively, these data suggest that nonencapsidated HBV DNA is sensed by cGAS but that this sensing is impaired during HBV infection.
THE cGAS-STING PATHWAY EXHIBITS ROBUST ANTIVIRAL ACTIVITY AGAINST HBV INFECTION WITH REDUCTION OF cccDNA LEVELS
Because cGAS exhibits antiviral activity against a broad range of DNA and RNA viruses (even in the absence of direct viral sensing), (20) we then investigated the antiviral effect of the cGAS-STING signaling pathway in HBV infection. We silenced the expression MB21D1, TMEM173 (encoding the STING protein), TBK1, and IFI16 (another cytoplasmic DNA sensor able to directly activate STING (17) ) in HepG2-NTCP cells prior to infection with HBV. Silencing of MB21D1, TMEM173, and TBK1 expression induced a marked increase in HBV infection (Fig. 6A,B) . In contrast, the silencing of IFI16 had no effect on HBV infection. CRISPR/Cas9-mediated KO or overexpression of cGAS protein resulted in a marked increase or decrease in HBV infection and HBV cccDNA levels-the key viral nucleic acid responsible for viral persistence ( Fig. 6C-E) . Notably, overexpression of cGAS did not affect NTCP expression at the cell surface, suggesting that the susceptibilities of the different cell lines to HBV infection are equivalent (Supporting Fig. S4 ). Taken together, our results suggest that cGAS is functional and exerts antiviral activity in HBV permissive cells.
HBV INFECTION INDUCES REPRESSION OF cGAS AND ITS EFFECTOR GENE EXPRESSION IN CELL CULTURE AND IN LIVER CHIMERIC MICE
Because several reports have suggested that HBV proteins can inhibit IFN-signaling pathways, (16) we next investigated whether HBV infection interferes with the expression of cGAS-related genes by quantifying MB21D1/cGAS mRNA and protein expression (Fig.  7A,B) . Interestingly, cGAS protein expression (Fig.  7B) as well as expression of MB21D1, TMEM173, and TBK1 mRNA (Fig. 7C) were significantly inhibited in HBV-infected cells. To confirm this observation in vivo, we then investigated the expression of human MB21D1 expression in HBV-infected human liver chimeric mice. MB21D1 was expressed at low but detectable levels (Fig. 7D) . MB21D1 expression was significantly (P 5 0.013) down-regulated in HBVinfected mice compared to noninfected control mice, confirming our results in the cell culture model (Fig.  7E) . Importantly, MB21D1 expression levels did not correlate with HBV genotype (Table 1 ). An absent correlation of human serum albumin with either MB21D1 expression ( Table 1 and Fig. 7E ) or status of HBV infection (Table 1 ; t test HBV versus control, P 5 0.26) largely excludes the possibility that the observed differences in cGAS expression are due to different human hepatocyte repopulation levels or to a decrease of human hepatocyte cell viability in individual animals. To investigate whether HBV modulates cGAS effector function, we analyzed virus-induced changes on cGAS effector gene expression using gene expression profiling in three control mice and the three HBV-infected mice exhibiting the lowest levels of MB21D1 expression (Table 1) . HBV infection resulted in a significant (FDR, 0.047) down-regulation of the expression of cGAS effector genes in human hepatocytes in chimeric mice (Fig. 7F) . The data showed that HBV represses expression of cGAS and its effector genes in vivo.
Discussion
The interaction between HBV and the innate immune system is a complex process that remains elusive and controversial. (15) Collectively, our data demonstrate that in human hepatocytes (1) naked HBV genomic rcDNA is sensed in a cGAS-dependent manner, whereas the packaged HBV genome appears not to be recognized during viral infection; (2) the cGAS-STING pathway exhibits antiviral activity against HBV infection including reduction of viral cccDNA levels; (3) HBV infection suppresses both cGAS expression and function in cell culture and humanized liver chimeric mice.
The detection of HBV DNA by the cellular sensors within infected cells is still poorly understood and (Supporting Fig. S3 ). HBV rcDNA (1 lg) and positive control dsDNA (1 lg) were transfected into HepG2-NTCP-Cas9 and HepG2-NTCP-KO_cGAS#2 cells. Three days after transfection, total RNA was extracted. Gene expression of IAR set was then analyzed using multiplexed gene profiling. The transcripts were analyzed by GSEA compared to nontransfected control (A) or by IFNB1 and IFI44 gene expression (log10) compared to nontransfected control (set at 1) (B). One experiment in triplicate is shown. (C) HBV DNA in HepG2-NTCP cells after rcDNA transfection and HBV infection are similar. HepG2-NTCP cells were infected with HBV or transfected with HBV rcDNA (1 lg). At day 2 after transfection/infection, DNA was extracted and total HBV DNA was quantified by quantitative PCR. Results are expressed as means 6 SD total DNA copies per microgram of total DNA (log10) from three independent experiments performed in triplicate (HBV infection) and two independent experiments performed in triplicate (HBV rcDNA transfection).
remains controversial. In vitro and in vivo data strongly suggest that HBV behaves like a stealth virus, unable to trigger any innate immune response. (8, 9, 11) Other studies have suggested that HBV-derived dsDNA fragments (25) and viral nucleocapsid destabilization and disassembly (38, 39) could induce innate immune responses. Our results demonstrate that in human hepatocytes-the natural target cell of HBV infection-exposure of the naked HBV genome leads to the activation of innate antiviral immune Results are expressed as means 6 SD percentage relative MB21D1 expression (log10) relative to control cell line (Ctrl_ORF, set at 1) from three independent experiments performed in duplicate. HepG2-NTCP, Ctrl_ORF, and cGAS_OE cells were then infected with HBV for 10 days, and HBV infection was assessed as described above. Results are expressed as means 6 SD percentage HBV pgRNA expression relative to control cell line (Ctrl_ORF, set at 100%) from three independent experiments performed in triplicate. (E) Detection of HBV cccDNA by Southern blot. HepG2-NTCP-derived cGAS_KO or cGAS_overexpressing cell lines were infected for 10 days with HBV. Total DNA from indicated HBV-infected cells was extracted, and HBV DNA was detected by Southern blot. Two different DNA ladders (L1, L2) were used. XhoI digestion of DNA extracted from HBV-infected HepG2-NTCP-Cas9 cells was used as a control and resulted in a single 3.2-kb band (dsl HBV DNA). Mitochondrial DNA was detected as a loading control. One experiment is shown. Abbreviations: NS, nonsignificant; OE, overexpressing.
responses. In contrast, sensing is largely absent during HBV infection, most likely due to packaging into the viral capsid. These results extend a previous observation in hepatoma cell lines transfected with replicationcompetent HBV DNA that the HBV genome itself can be recognized by the classical sensors. (25) Interestingly, the capsid of HIV-1 also prevents the sensing of HIV cDNA by cGAS following reversetranscription up to integration, whereas HIV-2 capsid may unmask the cDNA, leading to a stronger sensing by cGAS and a lower pathogenicity of the strain. (40) Another explanation of this absence of sensing would be the lack a functional STING protein in hepatocytes, as has been recently reported. (41) In our study, rcDNA and dsDNA were sensed in a cGASdependent manner and able to activate the cGAS- Results are expressed as means 6 SD from three experiments performed in triplicate. cGAS protein expression was assessed 10 days after infection (B, one experiment is shown). Gene expression relative to noninfected control cells of MB21D1, TMEM173, and TBK1 was assessed by quantitative RT-PCR at day 10 after infection (C). Results are expressed as means 6 SEM from three independent experiments performed in triplicate. (D,E) MB21D1 and IAR gene set expression is impaired in HBVinfected mice. uPA-SCID mice were infected with HBV for 16 weeks. Mice were then sacrificed, and HBV infection was assessed by HBV RNA-specific in situ hybridization (D) and quantification of HBV viral load in the serum (Table 1) . Human MB21D1 expression was detected in human hepatocytes by FISH from one HBV-infected mouse (D) and by quantitative RT-PCR from seven HBV-infected mice and four control mice (E, left panel). Results are expressed as the ratio MB21D1 mRNA/GAPDH mRNA. All individual mice are presented as well as means 6 SD for each group (mock and HBV-infected mice). The level of MB21D1 expression was independent of the viability of engrafted human hepatocytes as indicated by an absent correlation between MB21D1 expression and human serum albumin expression in humanized mice (R 2 5 0.231; E, right panel). (F) The IAR gene set was analyzed using the nCounter NanoString in mice 6472, 6251, and 6254 (mock infected mice, Table 1 ) and 4766, 4771, and 4847 (HBVinfected mice, Table 1 ). A significant down-regulation (FDR, 0.047) of the gene set was observed in HBV-infected mice compared to control mice. Individual Z scores for the genes significantly modulated between the two groups according to GSEA are presented. Negative Z score (blue) and positive Z score (red) correspond to repression and induction of the indicated genes, respectively. Abbreviation: Dpi, days postinfection. 
